AAAAAA

   
Results: 1-7 |
Results: 7
Correlation of human CD56(+) cell cytotoxicity and IFN-gamma production
Authors: Derby, EG Reddy, V Nelson, EL Kopp, WC Baseler, MW Dawson, JR Malyguine, AM
Citation: Eg. Derby et al., Correlation of human CD56(+) cell cytotoxicity and IFN-gamma production, CYTOKINE, 13(2), 2001, pp. 85-90
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia
Authors: Arun, B Curti, BD Longo, DL Stevens, D Alvord, WG Gause, BL Watson, T Kopp, WC Janik, JE
Citation: B. Arun et al., Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia, CA J SCI AM, 6(1), 2000, pp. 21-24
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer
Authors: Zujewski, J Horak, ID Bol, CJ Woestenborghs, R Bowden, C End, DW Piotrovsky, VK Chiao, J Belly, RT Todd, A Kopp, WC Kohler, DR Chow, C Noone, M Hakim, FT Larkin, G Gress, RE Nussenblatt, RB Kremer, AB Cowan, KH
Citation: J. Zujewski et al., Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer, J CL ONCOL, 18(4), 2000, pp. 927-941
Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients
Authors: Janik, JE Miller, LL Kopp, WC Taub, DD Dawson, H Stevens, D Kostboth, P Curti, BD Conlon, KC Dunn, BK Donegan, SE Ullrich, R Alvord, WG Gause, BL Longo, DL
Citation: Je. Janik et al., Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients, CLIN IMMUNO, 93(3), 1999, pp. 209-221
Conditioned immune response to interferon-gamma in humans
Authors: Longo, DL Duffey, PL Kopp, WC Heyes, MP Alvord, WG Sharfman, WH Schmidt, PJ Rubinow, DR Rosenstein, DL
Citation: Dl. Longo et al., Conditioned immune response to interferon-gamma in humans, CLIN IMMUNO, 90(2), 1999, pp. 173-181
Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation
Authors: Nelson, EL Strobl, S Subleski, J Prieto, D Kopp, WC Nelson, PJ
Citation: El. Nelson et al., Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation, FASEB J, 13(14), 1999, pp. 2021-2030
Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin
Authors: Miller, LL Korn, EL Stevens, DS Janik, JE Gause, BL Kopp, WC Holmlund, JT Curti, BD Sznol, M Smith, JW Urba, WJ Donegan, SE Watson, TM Longo, DL
Citation: Ll. Miller et al., Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin, BLOOD, 93(10), 1999, pp. 3250-3258
Risultati: 1-7 |